'The De Novo request provides a marketing pathway to classify novel medical devices for which general controls alone, or general and special controls, provide reasonable assurance of safety and effectiveness for the intended use, but for which there is no legally marketed predicate device.4 Oct 2022.'
- Forums
- ASX - By Stock
- Ann: Optiscan Intends to pursue De Novo Pathway for InVivage
'The De Novo request provides a marketing pathway to classify...
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OIL (ASX) to my watchlist
(20min delay)
|
|||||
Last
10.5¢ |
Change
0.007(7.14%) |
Mkt cap ! $87.71M |
Open | High | Low | Value | Volume |
10.5¢ | 10.5¢ | 10.5¢ | $10.5K | 100K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 6200 | 10.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.5¢ | 246683 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 6200 | 0.100 |
4 | 69387 | 0.098 |
1 | 10000 | 0.097 |
2 | 75000 | 0.096 |
2 | 150000 | 0.095 |
Price($) | Vol. | No. |
---|---|---|
0.105 | 246683 | 4 |
0.115 | 31600 | 2 |
0.120 | 143007 | 2 |
0.125 | 124007 | 2 |
0.130 | 67301 | 3 |
Last trade - 10.06am 21/05/2024 (20 minute delay) ? |
|
|||||
Last
10.5¢ |
  |
Change
0.007 ( 7.14 %) |
|||
Open | High | Low | Volume | ||
10.5¢ | 10.5¢ | 10.5¢ | 22349 | ||
Last updated 13.11pm 21/05/2024 ? |
Featured News
OIL (ASX) Chart |
The Watchlist
AUQ
ALARA RESOURCES LIMITED
Stephen Gethin, Non-Executive Director & Chairman
Stephen Gethin
Non-Executive Director & Chairman
Previous Video
Next Video
SPONSORED BY The Market Online